Expression patterns of multidrug-resistance (mdr1), multidrug resistance-associated protein (MRP), glutathione-S-transferase-π (GST-π) and DNA topoisomerase II (Topo II) genes in renal cell carcinomas and normal kidney

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 506-511

  Kim, Wun Jae ^a   Kakehi, Yoshiyuki ^a   Kinoshita, Hidefumi ^a   Arao, Shinji ^a   Fukumoto, Manabu ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Carcinoma; Renal cell; glutathione transferases; DNA topoisomerase (ATP hydrolysing)

Indexed keywords

ABC TRANSPORTER; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; STATISTICAL MODEL;

ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CARCINOMA, RENAL CELL; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LINEAR MODELS; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 0030213563     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(01)65915-9     Document Type: Article

References (27)

1. Gottesman, M. M. and Pastan, I.: The multidrug transporter, a double edged sword. J. Biol. Chem., 263: 12163, 1988.
2. Zaman, G. J. R., Flens, M. J., Van Leusden, M. R., De Haas, M., Mulder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., Broxterman, H. J. and Borst, P.: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. U.S.A., 91: 8822, 1994.
3. Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E. and Cowan, K. H.: Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261: 15544, 1986.
4. Lock, R. B. and Ross, W. E.: DNA-topoisomerase in cancer-therapy. Anticancer Drug Des., 2: 151, 1987.
5. De Jong, S., Zijlstra, J. G., De Vries, E. G. E. and Mulder, N. H.: Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 50: 304, 1990.
6. Weinstein, R. S., Jakate, S. M., Dominguez, J. M., Lebovitz, M. D., Koukoulis, G. K., Kuszak, J. R., Klusens, L. F., Grogan, T. M., Saclarides, T. J., Roninson, I. B. and Coon, J. S.: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res., 51: 2720, 1991.
7. Chin, K. V., Ueda, K., Pastan, I. and Gottesman, M. M.: Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science, 255: 459, 1992.
8. Bordow, S. B., Haber, M., Madafiglio, J., Cheung, B., Marshall, G. M. and Norris, M. D.: Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res., 54: 5036, 1994.
9. Volm, M., Kästel, M., Mattern, J. and Efferth, T.: Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer, 71: 3981, 1993.
10. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., von Hoff, D. D. and Roninson, I. B.: Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A., 87: 7160, 1990.
11. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
12. Kim, W.-J., Kakehi, Y., Hirai, M., Arao, S., Hiai, H., Fukumoto, M. and Yoshida, O.: Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line. Jpn. J. Cancer Res., 86: 969, 1995.
13. Mandai, M., Konishi, I., Koshiyama, M., Mori, T., Arao, S., Tashiro, H., Okamura, H., Nomura, H., Hiai, H. and Fukumoto, M.: Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res., 54: 1825, 1994.
14. Farber, E.: Cellular biochemistry of the stepwise development of cancer with chemicals: G. H. A. Clowes Memorial Lecture. Cancer Res., 44: 5463, 1984.
15. Fairchild, C. R., Ivy, S. P., Rushmore, T., Lee, G., Koo, P., Goldsmith, M. E., Myers, C. E., Farber, E. and Cowan, K. H.: Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci., U.S.A., 84:7701, 1987.
16. Schneider, J., Rubio, M. P., Barbazan, M. J., Rodriguez, E. F. J., Seizinger, B. R. and Castresana, J. S.: P-glycoprotein, HER-2/ neu, and mutant p53 expression in human gynecologic tumors. J. Natl. Cancer Inst., 86: 850, 1994.
17. Duensing, S., Dallmann, I., Grosse, J., Buer, J., Hänninen, E. L., Deckert, M., Störkel, S., Kirchner, H., Poliwoda, H. and Atzpodien, J.: Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients. Oncology, 51: 309, 1994.
18. Arao, S., Suwa, H., Mandai, M., Tashiro, H., Miyazaki, K., Okamura, H., Nomura, H., Hiai, H. and Fukumoto, M.: Expression of multidrug resistance gene localization of P-glycoprotein in human primary ovarian cancer. Cancer Res., 54: 1355, 1994.
19. Kakehi, Y., Wu, W.-J., Kim, W.-J., Arao, S., Fukumoto, M. and Yoshida, O.: Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers. Int. J. Urol., 2: 309, 1995.
20. Chin, K.-V., Tanaka, S., Darlington, G., Pastan, I. and Gottesman, M. M.: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal cell carcinoma cells. J. Biol. Chem., 265: 221, 1990.
21. Matsuo, K., Kohno, K., Sato, S., Uchiumi, T., Tanimura, H., Yamada, Y. and Kuwano, M.: Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Res., 53: 1085, 1993.
22. Efferth, T., Mattern, J. and Volm, M.: Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors. Oncology, 49: 368, 1992.
23. Niitsu, Y., Takahashi, Y., Saito, T., Hirata, Y., Arisato, N., Maruyama, H., Kohgo, Y. and Listowsky, I.: Serum glutathione-S-transferase-π as a tumor marker for gastrointestinal malignancies. Cancer, 63: 317, 1989.
24. Kovacs, G.: The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours. World J. Urol., 12: 64, 1994.
25. Fuzesi, L., Cober, M. and Mittermayer, C.: Collecting duct carcinoma: cytogenetic characterization. Histopathology, 21: 155, 1992.
26. Wilhelm, M., Krause, U. and Kovacs, G.: Diagnosis and prognosis of renal-cell tumors: a molecular approach. World J. Urol., 13: 143, 1995.
27. Sene, A. P., Hunt, L., McMahon, R. F. T. and Carroll, R. N. P.: Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br. J. Urol., 70: 125, 1992.